Psychiatric Solutions Announces Third Quarter 2010 Earnings of $0.94 per Diluted Share on 10.4% Growth in Same-Facility Revenue
FRANKLIN, Tenn.--([ BUSINESS WIRE ])--Psychiatric Solutions, Inc. (aPSIa) (NASDAQ: PSYS) today announced financial results for the third quarter ended September 30, 2010. Revenue increased 12.2% for the quarter to $508.5 million from $453.2 million for the third quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 89.7% to $53.7 million for the third quarter of 2010 from $28.3 million for the third quarter last year and 88.0% per diluted share to $0.94 from $0.50. Results for the third quarter of 2010 included transaction costs of approximately $2.4 million, which were related to PSIa™s previously announced definitive agreement providing for the acquisition of PSI by Universal Health Services, Inc.
PSIa™s same-facility revenue for the third quarter of 2010 grew 10.4% from the third quarter of 2009, primarily due to a 4.0% increase in patient days and a 6.1% increase in revenue per patient day. The Company expanded its same-facility EBITDA margin to 27.3% for the third quarter from 20.7% for the third quarter of 2009. Consolidated adjusted EBITDA increased 51.6% to $121.5 million, or 23.9% of revenue, for the third quarter of 2010 from $80.2 million, or 17.7% of revenue, for the third quarter of 2009. A reconciliation of all GAAP and non-GAAP financial results in this release can be found on page 5.
Net cash from continuing operating activities for the third quarter of 2010 increased 85.5% from the third quarter of 2009 to $68.9 million. Capital expenditures, primarily for maintenance and the addition of beds to facilities, totaled $24.8 million for the quarter. PSI made $51.2 million of principal payments on long-term debt during the quarter, including a $50 million optional prepayment on its senior secured term loan. PSIa™s ratio of debt to total capitalization improved to 48.2% at the end of the third quarter of 2010 from 50.6% at the end of the second quarter of 2010 and 56.2% at the end of the third quarter of 2009. In addition, the ratio of debt to adjusted EBITDA for the trailing 12 months improved to 2.8 at the end of the third quarter of 2010 from 3.3 at the end of the second quarter of 2010 and 4.0 at the end of the third quarter last year. PSI completed the third quarter of 2010 with $43.4 million in cash and cash equivalents and no borrowings under its $300 million revolving credit facility.
PSI offers an extensive continuum of behavioral health programs to critically ill children, adolescents and adults and is the largest operator of owned or leased freestanding psychiatric inpatient facilities with over 11,000 beds in 32 states, Puerto Rico and the U.S. Virgin Islands. PSI also manages freestanding psychiatric inpatient facilities for government agencies and psychiatric inpatient units within medical/surgical hospitals owned by others.
PSYCHIATRIC SOLUTIONS, INC. | ||||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||||
(Unaudited, in thousands except for per share amounts) | ||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||||||||
Revenue | $ | 508,544 | $ | 453,187 | $ | 1,487,194 | $ | 1,342,404 | ||||||||||||||
Salaries, wages and employee benefits (including share-based compensation of $4,946, $4,249, $12,738 and $13,525 for the respective three and nine month periods in 2010 and 2009) | 256,713 | 252,617 | 779,486 | 746,807 | ||||||||||||||||||
Professional fees | 46,921 | 42,040 | 142,567 | 124,332 | ||||||||||||||||||
Supplies | 24,350 | 23,137 | 72,332 | 69,549 | ||||||||||||||||||
Rentals and leases | 4,893 | 5,040 | 14,571 | 15,169 | ||||||||||||||||||
Other operating expenses | 50,216 | 44,600 | 157,427 | 126,687 | ||||||||||||||||||
Provision for doubtful accounts | 8,615 | 9,817 | 30,552 | 26,569 | ||||||||||||||||||
Depreciation and amortization | 12,968 | 11,436 | 38,237 | 32,904 | ||||||||||||||||||
Interest expense | 16,663 | 18,551 | 49,714 | 53,263 | ||||||||||||||||||
421,339 | 407,238 | 1,284,886 | 1,195,280 | |||||||||||||||||||
Income from continuing operations before income taxes | 87,205 | 45,949 | 202,308 | 147,124 | ||||||||||||||||||
Provision for income taxes | 33,277 | 17,651 | 77,572 | 56,380 | ||||||||||||||||||
Income from continuing operations | 53,928 | 28,298 | 124,736 | 90,744 | ||||||||||||||||||
Loss from discontinued operations, net of taxes | (796 | ) | (153 | ) | (8,221 | ) | (464 | ) | ||||||||||||||
Net income | 53,132 | 28,145 | 116,515 | 90,280 | ||||||||||||||||||
Less: Net income attributable to noncontrolling interest | (247 | ) | 7 | (297 | ) | (338 | ) | |||||||||||||||
Net income attributable to PSI stockholders | $ | 52,885 | $ | 28,152 | $ | 116,218 | $ | 89,942 | ||||||||||||||
Basic earnings per share: | ||||||||||||||||||||||
Income from continuing operations attributable to PSI stockholders | $ | 0.96 | $ | 0.51 | $ | 2.23 | $ | 1.63 | ||||||||||||||
Loss from discontinued operations, net of taxes | (0.01 | ) | - | (0.15 | ) | (0.01 | ) | |||||||||||||||
Net income attributable to PSI stockholders | $ | 0.95 | $ | 0.51 | $ | 2.08 | $ | 1.62 | ||||||||||||||
Diluted earnings per share: | ||||||||||||||||||||||
Income from continuing operations attributable to PSI stockholders | $ | 0.94 | $ | 0.50 | $ | 2.19 | $ | 1.61 | ||||||||||||||
Loss from discontinued operations, net of taxes | (0.02 | ) | - | (0.15 | ) | (0.01 | ) | |||||||||||||||
Net income attributable to PSI stockholders | $ | 0.92 | $ | 0.50 | $ | 2.04 | $ | 1.60 | ||||||||||||||
Shares used in computing per share amounts: | ||||||||||||||||||||||
Basic | 55,945 | 55,579 | 55,850 | 55,545 | ||||||||||||||||||
Diluted | 57,356 | 56,340 | 56,913 | 56,077 | ||||||||||||||||||
Amounts attributable to PSI stockholders: | ||||||||||||||||||||||
Income from continuing operations | $ | 53,681 | $ | 28,305 | $ | 124,439 | $ | 90,406 | ||||||||||||||
Loss from discontinued operations, net of taxes | (796 | ) | (153 | ) | (8,221 | ) | (464 | ) | ||||||||||||||
Net income | $ | 52,885 | $ | 28,152 | $ | 116,218 | $ | 89,942 |
PSYCHIATRIC SOLUTIONS, INC. | |||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
(Unaudited, in thousands) | |||||||||||
September 30, | December 31, | ||||||||||
2010 | 2009 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 43,422 | $ | 6,815 | |||||||
Accounts receivable, less allowance for doubtful accounts of $53,710 and $51,894, respectively | 258,822 | 249,439 | |||||||||
Other current assets | 94,155 | 105,166 | |||||||||
Total current assets | 396,399 | 361,420 | |||||||||
Property and equipment, net of accumulated depreciation | 977,250 | 931,730 | |||||||||
Cost in excess of net assets acquired | 1,153,111 | 1,153,111 | |||||||||
Other assets | 57,009 | 60,979 | |||||||||
Total assets | $ | 2,583,769 | $ | 2,507,240 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 35,709 | $ | 35,397 | |||||||
Salaries and benefits payable | 97,930 | 81,129 | |||||||||
Other accrued liabilities | 91,871 | 62,036 | |||||||||
Current portion of long-term debt | 4,436 | 4,940 | |||||||||
Total current liabilities | 229,946 | 183,502 | |||||||||
Long-term debt, less current portion | 1,075,182 | 1,182,139 | |||||||||
Deferred tax liability | 81,786 | 81,137 | |||||||||
Other liabilities | 31,097 | 25,790 | |||||||||
Total liabilities | 1,418,011 | 1,472,568 | |||||||||
Redeemable noncontrolling interest | 4,583 | 4,337 | |||||||||
Total stockholders' equity | 1,161,175 | 1,030,335 | |||||||||
Total liabilities and stockholders' equity | $ | 2,583,769 | $ | 2,507,240 |
PSYCHIATRIC SOLUTIONS, INC. | ||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||
(Unaudited, in thousands) | ||||||||||||
Nine Months Ended September 30, | ||||||||||||
2010 | 2009 | |||||||||||
Operating activities: | ||||||||||||
Net income | $ | 116,515 | $ | 90,280 | ||||||||
Adjustments to reconcile net income to net cash provided by continuing operating activities: | ||||||||||||
Depreciation and amortization | 38,237 | 32,904 | ||||||||||
Amortization of loan costs and bond discount | 4,728 | 3,574 | ||||||||||
Share-based compensation | 12,738 | 13,525 | ||||||||||
Change in income tax assets and liabilities | 45,472 | 15,624 | ||||||||||
Loss from discontinued operations, net of taxes | 8,221 | 464 | ||||||||||
Changes in operating assets and liabilities, net of effect of acquisitions: | ||||||||||||
Accounts receivable | (9,383 | ) | (4,611 | ) | ||||||||
Prepaids and other current assets | (7,527 | ) | 771 | |||||||||
Accounts payable | 3,606 | (1,707 | ) | |||||||||
Salaries and benefits payable | 16,801 | 3,421 | ||||||||||
Accrued liabilities and other liabilities | (5,364 | ) | 995 | |||||||||
Net cash provided by continuing operating activities | 224,044 | 155,240 | ||||||||||
Net cash provided by (used in) discontinued operating activities | 1,189 | (252 | ) | |||||||||
Net cash provided by operating activities | 225,233 | 154,988 | ||||||||||
Investing activities: | ||||||||||||
Cash paid for acquisitions, net of cash acquired | - | (32,708 | ) | |||||||||
Cash paid for real estate acquisitions | - | (18,996 | ) | |||||||||
Capital purchases of property and equipment | (82,371 | ) | (95,392 | ) | ||||||||
Other assets | 35 | 389 | ||||||||||
Net cash used in continuing investing activities | (82,336 | ) | (146,707 | ) | ||||||||
Net cash used in discontinued investing activities | (12 | ) | (221 | ) | ||||||||
Net cash used in investing activities | (82,348 | ) | (146,928 | ) | ||||||||
Financing activities: | ||||||||||||
Net decrease in revolving credit facility | - | (138,374 | ) | |||||||||
Borrowings on long-term debt | - | 106,500 | ||||||||||
Principal payments on long-term debt | (109,176 | ) | (3,823 | ) | ||||||||
Payment of loan and issuance costs | (27 | ) | (9,826 | ) | ||||||||
Distributions to noncontrolling interests | (51 | ) | (723 | ) | ||||||||
Excess tax benefits from share-based payment arrangements | - | 208 | ||||||||||
Repurchase of common stock upon restricted stock vesting | (490 | ) | (992 | ) | ||||||||
Proceeds from exercises of common stock options | 3,466 | 1,065 | ||||||||||
Net cash used in financing activities | (106,278 | ) | (45,965 | ) | ||||||||
Net increase (decrease) in cash | 36,607 | (37,905 | ) | |||||||||
Cash and cash equivalents at beginning of the period | 6,815 | 51,271 | ||||||||||
Cash and cash equivalents at end of the period | $ | 43,422 | $ | 13,366 |
PSYCHIATRIC SOLUTIONS, INC. | ||||||||||||||||||
RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO EBITDA AND ADJUSTED EBITDA | ||||||||||||||||||
(Unaudited, in thousands) | ||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||||
Income from continuing operations attributable to PSI stockholders | $ | 53,681 | $ | 28,305 | $ | 124,439 | $ | 90,406 | ||||||||||
Provision for income taxes | 33,277 | 17,651 | 77,572 | 56,380 | ||||||||||||||
Interest expense | 16,663 | 18,551 | 49,714 | 53,263 | ||||||||||||||
Depreciation and amortization | 12,968 | 11,436 | 38,237 | 32,904 | ||||||||||||||
EBITDA(a) | 116,589 | 75,943 | 289,962 | 232,953 | ||||||||||||||
Other expenses: | ||||||||||||||||||
Share-based compensation | 4,946 | 4,249 | 12,738 | 13,525 | ||||||||||||||
Adjusted EBITDA(a) | $ | 121,535 | $ | 80,192 | $ | 302,700 | $ | 246,478 | ||||||||||
(a) | EBITDA and adjusted EBITDA are non-GAAP financial measures. EBITDA is defined as income from continuing operations attributable tostockholders before interest expense (net of interest income), income taxes, depreciation and amortization. Adjusted EBITDA is defined asincome from continuing operations attributable to stockholders before interest expense (net of interest income), income taxes, depreciation,amortization, and other items included in the caption above labeled aOther expensesa. These other expenses may occur in future periods butthe amounts recognized can vary significantly from period to period and do not directly relate to the ongoing operations of our healthcare facilities. PSIa™s management relies on EBITDA and adjusted EBITDA as the primary measures to review and assess operatingperformance of its facilities and their management teams. PSI believes it is useful to investors to provide disclosures of its operating resultson the same basis as that used by management. Management and investors also review EBITDA and adjusted EBITDA to evaluate PSIa™soverall performance and to compare PSIa™s current operating results with corresponding periods and with other companies in the healthcare industry. You should not consider EBITDA and adjusted EBITDA in isolation or as a substitute for net income, operating cash flows orother cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Because EBITDAand adjusted EBITDA are not measures of financial performance under accounting principles generally accepted in the United Statesand are susceptible to varying calculations, they may not be comparable to similarly titled measures of other companies. | |||||||||||||||||
PSYCHIATRIC SOLUTIONS, INC. | ||||||||||||||
OPERATING STATISTICS - OWNED FACILITIES | ||||||||||||||
(Unaudited) | ||||||||||||||
(Revenue in thousands) | ||||||||||||||
Three Months Ended September 30, | % | |||||||||||||
2010 | 2009 | Change | ||||||||||||
Same-facility results: | ||||||||||||||
Revenue | $ | 464,021 | $ | 420,421 | 10.4% | |||||||||
Admissions | 48,491 | 44,799 | 8.2% | |||||||||||
Patient days | 745,759 | 717,089 | 4.0% | |||||||||||
Average length of stay(a) | 15.4 | 16.0 | -3.8% | |||||||||||
Revenue per patient day(b) | $ | 622 | $ | 586 | 6.1% | |||||||||
EBITDA margin | 27.3 | % | 20.7 | % | 660 bps | |||||||||
Total facility results: | ||||||||||||||
Revenue | $ | 471,391 | $ | 420,421 | 12.1% | |||||||||
Admissions | 49,573 | 44,799 | 10.7% | |||||||||||
Patient days | 755,277 | 717,089 | 5.3% | |||||||||||
Average length of stay(a) | 15.2 | 16.0 | -5.0% | |||||||||||
Revenue per patient day(b) | $ | 624 | $ | 586 | 6.5% | |||||||||
EBITDA margin | 27.2 | % | 20.7 | % | 650 bps | |||||||||
Nine Months Ended September 30, | % | |||||||||||||
2010 | 2009 | Change | ||||||||||||
Same-facility results: | ||||||||||||||
Revenue | $ | 1,353,119 | $ | 1,248,314 | 8.4% | |||||||||
Admissions | 144,482 | 132,881 | 8.7% | |||||||||||
Patient days | 2,246,412 | 2,145,861 | 4.7% | |||||||||||
Average length of stay(a) | 15.5 | 16.1 | -3.7% | |||||||||||
Revenue per patient day(b) | $ | 602 | $ | 582 | 3.4% | |||||||||
EBITDA margin | 24.4 | % | 21.5 | % | 290 bps | |||||||||
Total facility results: | ||||||||||||||
Revenue | $ | 1,381,279 | $ | 1,248,314 | 10.7% | |||||||||
Admissions | 148,248 | 132,881 | 11.6% | |||||||||||
Patient days | 2,280,722 | 2,145,861 | 6.3% | |||||||||||
Average length of stay(a) | 15.4 | 16.1 | -4.3% | |||||||||||
Revenue per patient day(b) | $ | 606 | $ | 582 | 4.1% | |||||||||
EBITDA margin | 24.3 | % | 21.5 | % | 280 bps | |||||||||
(a) | Average length of stay is defined as patient days divided by admissions. | |||||||||||||
(b) | Revenue per patient day is defined as owned facility revenue divided by patient days. | |||||||||||||